Sort
25,944 grants matching “neurodegeneration”
Ligand Regulated Epigenetic/Nuclear Architectural Strategies and Human Disease
$447,687Michael G Rosenfeld · University Of California, San Diego · R01 · FY2010 · NS
Exploring the contribution of astrocytes to Huntington disease
$447,612Michelle Gray · University Of Alabama At Birmingham · R01 · FY2022 · NS
CB1-mediated signaling in developmental ethanol effects
$447,588Basavaraj S Balapal · Nathan S. Kline Institute For Psych Res · R01 · FY2025 · AA
Nanoparticle-mediated reduction of oxidative stress for the treatment of traumatic brain injury
$447,459Forrest M Kievit · University Of Nebraska Lincoln · R01 · FY2019 · NS
iPSC-derived Neurovascular Organoids
$447,401Ethan Lippmann · Vanderbilt University · R01 · FY2022 · NS
IMPACTS OF GLIAL LIPID DROPLETS ON OXIDATIVE STRESS AND NEURODEGENERATION IN ALZHEIMER'S DISEASE
$447,262Hugo J Bellen · Baylor College Of Medicine · R01 · FY2025 · AG
Metabolic basis of the NADPH-independent disulfide reductase system in mouse liver
$447,254Edward E Schmidt · Montana State University - Bozeman · R01 · FY2020 · DK
Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease
$447,211Anil G Cashikar · Washington University · R01 · FY2025 · AG
iPSC-derived Neurovascular Organoids
$447,019Ethan Lippmann · Vanderbilt University · R01 · FY2021 · NS
Targeting immune receptors to prevent age-related neuroinflammation
$447,000Rachel A. Kohman · University Of North Carolina Wilmington · R15 · FY2017 · AG
Traumatic Axonal Injury: Tau and Amyloid Pathogenesis in vitro
$446,875Douglas Hamilton Smith · University Of Pennsylvania · R21 · FY2024 · NS
Engineering therapeutic TRIM11 disaggregases for Alzheimer's Disease-Related Dementias (ADRDs)
$446,875James Shorter · University Of Pennsylvania · R21 · FY2022 · AG
Pathological role of c-Abl in alpha-synucleinoapathy
$446,857Michael K Lee · University Of Minnesota · R01 · FY2019 · NS
Pathological role of c-Abl in alpha-synucleinoapathy
$446,857Michael K Lee · University Of Minnesota · R01 · FY2020 · NS
The role of activity induced exosome signaling in synaptic pathology of Alzheimer's Disease
$446,851Jeffrey Nicholas Savas · Northwestern University At Chicago · R01 · FY2022 · AG
REST-Activated Program of Gene Expression in Ischemia
$446,818R. Suzanne Zukin · Albert Einstein College Of Medicine · R01 · FY2011 · NS
Biophysical investigation of the impact of cargo membrane fluidity on multiple-motor transport
$446,763Jing Xu · University Of California, Merced · R15 · FY2016 · GM
Molecular Basis of Factors Controlling Prion Strain Diversity and Species Barrier
$446,600Claudio Soto · Case Western Reserve University · P01 · FY2017 · AI
Nanoparticle-mediated reduction of oxidative stress for the treatment of traumatic brain injury
$446,587Forrest M Kievit · University Of Nebraska Lincoln · R01 · FY2021 · NS
Preventing and Reversing Mitochondrial Leigh Syndrome with Hypoxia
$446,502Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2025 · NS
Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models
$446,500Darren John Moore · Van Andel Research Institute · R01 · FY2021 · NS
Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models
$446,500Darren John Moore · Van Andel Research Institute · R01 · FY2023 · NS
Epigenetic contributions to symptom asymmetry in Parkinson's disease
$446,500Gerhard A Coetzee · Van Andel Research Institute · R01 · FY2020 · NS
Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models
$446,500Darren John Moore · Van Andel Research Institute · R01 · FY2020 · NS
Epigenetic contributions to symptom asymmetry in Parkinson's disease
$446,500Gerhard A Coetzee · Van Andel Research Institute · R01 · FY2023 · NS